Fluid resuscitation in human sepsis: Time to rewrite history?

Annals of Intensive Care

Volumn 7, Issue 1, 2017, Pages

  Byrne, Liam ^a,b   Van Haren, Frank ^a,b  

^a The Australian National University   (Australia)

^b CANBERRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

LACTIC ACID;

CLINICAL PRACTICE; FLUID RESUSCITATION; HEMODYNAMICS; HUMAN; NONHUMAN; OLIGURIA; OXYGEN CONSUMPTION; PRECLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEPSIS; SEPTIC SHOCK;

EID: 85008324924     PISSN: None     EISSN: 21105820     Source Type: Journal    
DOI: 10.1186/s13613-016-0231-8     Document Type: Review

References (114)

1. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348(16):1546–54.
2. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL. Facing the challenge: decreasing case fatality rates in severe sepsis despite increasing hospitalizations. Crit Care Med Baltim. 2005;33(11):2555.
3. Sundararajan V, MacIsaac CM, Presneill JJ, Cade JF, Visvanathan K. Epidemiology of sepsis in Victoria, Australia. Crit Care Med. 2005;33(1):71–80.
4. Harrison DA, Welch CA, Eddleston JM. The epidemiology of severe sepsis in England, Wales and Northern Ireland, 1996 to 2004: secondary analysis of a high quality clinical database, the ICNARC Case Mix Programme Database. Crit Care. 2006;10(2):R42.
5. Daniels R. Surviving the first hours in sepsis: getting the basics right (an intensivist’s perspective). J Antimicrob Chemother. 2011;66(suppl 2):ii11–23.
6. Vincent J, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med Baltim. 2006;34(2):344.
7. Suffredini AF, Munford RS. Novel therapies for septic shock over the past 4 decades. JAMA. 2011;306(2):194–9.
8. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med Baltim. 2001;29(7):1303–10.
9. Winslow EJ, Loeb HS, Rahimtoola SH, Kamath S, Gunnar RM. Hemodynamic studies and results of therapy in 50 patients with bacteremic shock. Am J Med. 1973;54(4):421–32.
10. Cosnett J. The origins of intravenous fluid therapy. The Lancet. 1989;333(8641):768–71.
11. Hollenberg S, Ahrens T, Astiz M, Chalfin D, Dasta J, Heard S, et al. Practice parameters for hemodynamic support of sepsis in adult patients in sepsis. Crit Care Med. 1999;27(3):639–60.
12. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39(2):165–228.
13. van Haren F, Zacharowski K. What’s new in volume therapy in the intensive care unit? Best Pract Res Clin Anaesthesiol. 2014;28(3):275–83.
14. Awad S, Allison SP, Lobo DN. The history of 0.9% saline. Clin Nutr. 2008;27(2):179–88.
15. Barsoum N, Kleeman C. Now and then, the history of parenteral fluid administration. Am J Nephrol. 2002;22(2–3):284–9.
16. O’shaughnessy W. Experiments on the blood in cholera. The Lancet. 1831;17(435):490.
17. Foëx B. How the cholera epidemic of 1831 resulted in a new technique for fluid resuscitation. Emerg Med J. 2003;20(4):316–8.
18. Richards B. Case of severe post-partum haemorrhage successfully treated by intra-venous injection of saline fluid. The Lancet. 1888;131(3359):67.
19. Jennings CE. The intra-venous injection of fluid for severe haemorrhage. The Lancet. 1882;120(3081):436–7.
20. The intra-venous injection of saline fluid. The Lancet. 1894;143(3672):105–6.
21. Coates W. Two cases of intra-venous injection of fluids for severe haemorrhage. The Lancet. 1882;120(3096):1110–2.
22. Thomas WT. Injection of saline solution in shock. The Lancet. 1898;152(3926):1390–1.
23. Millham FH. A brief history of shock. Surgery. 2010;148(5):1026–37.
24. Manji RA, Wood KE, Kumar A. The history and evolution of circulatory shock. Crit Care Clin. 2009;25(1):1–29.
25. Lockhart Mummery J. The physiology and treatment of surgical shock and collapse. I. Lancet. 1905;1:696–703.
26. Crile GW. An experimental research into surgical shock: an essay awarded the Cartwright Prize for 1897. Philadelphia: JB Lippincott; 1899.
27. Pilcher LS. Blood-pressure in surgery and the treatment of surgical shock. Ann Surg. 1904;39(2):310.
28. Soto-Ruiz KM, Varon J, George W. Crile: a visionary mind in resuscitation. Resuscitation. 2009;80(1):6–8.
29. The nature and treatment of wound shock. The Lancet. 1918;191(4932):375–6.
30. The treatment of shock. The Lancet. 1908;172(4428):102–3.
31. Blalock A. Shock and hemorrhage. Bull N Y Acad Med. 1936;12:610–6.
32. Villazon S, Sierra U, Lopez S, Rolando M. Hemodynamic patterns in shock and critically ill patients. Crit Care Med. 1975;3(6):215–21.
33. Parker MM, Shelhamer JH, Natanson C, Alling DW, Parrillo JE. Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: heart rate as an early predictor of prognosis. Crit Care Med. 1987;15(10):923–9.
34. Suffredini AF, Fromm RE, Parker MM, Brenner M, Kovacs JA, Wesley RA, et al. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med. 1989;321(5):280–7.
35. MacLean LD, Mulligan WG, McLean A, Duff JH. Patterns of septic shock in man—a detailed study of 56 patients. Ann Surg. 1967;166(4):543.
36. Dietzman RH, Ersek RA, Bloch JM, Lillehei RC. High-output, low-resistance gram-negative septic shock in man. Angiology. 1969;20(11):691–700.
37. Gilbert EM, Haupt MT, Mandanas RY, Huaringa AJ, Carlson RW. The effect of fluid loading, blood transfusion, and catecholamine infusion on oxygen delivery and consumption in patients with sepsis 1, 2. Am Rev Respir Dis. 1986;134(5):873–8.
38. Hollenberg SM, Ahrens TS, Annane D, Astiz ME, Chalfin DB, Dasta JF, et al. Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med. 2004;32(9):1928–48.
39. Rivers EP, Coba V, Visbal A, Whitmill M, Amponsah D. Management of sepsis: early resuscitation. Clin Chest Med. 2008;29(4):689–704.
40. Dantzker D. Oxygen delivery and utilization in sepsis. Crit Care Clin. 1989;5(1):81–98.
41. Astiz ME, Rackow EC, Falk JL, Kaufman BS, Weil MH. Oxygen delivery and consumption in patients with hyperdynamic septic shock. Crit Care Med. 1987;15(1):26–8.
42. Boekstegers P, Weidenhöfer S, Kapsner T, Werdan K. Skeletal muscle partial pressure of oxygen in patients with sepsis. Crit Care Med. 1994;22(4):640–50.
43. Boekstegers P, Weidenhöfer S, Pilz G, Werdan K. Peripheral oxygen availability within skeletal muscle in sepsis and septic shock: comparison to limited infection and cardiogenic shock. Infection. 1991;19(5):317–23.
44. Hotchkiss RS, Karl IE. Reevaluation of the role of cellular hypoxia and bioenergetic failure in sepsis. JAMA. 1992;267(11):1503–10.
45. Jepson M, Cox M, Bates P, Rothwell N, Stock M, Cady E, et al. Regional blood flow and skeletal muscle energy status in endotoxemic rats. Am J Physiol Endocrinol Metabol. 1987;252(5):E581–7.
46. Hotchkiss R, Long R, Hall J, Shires G, Brouillard R, Millikan W, et al. An in vivo examination of rat brain during sepsis with 31P-NMR spectroscopy. Am J Physiol Cell Physiol. 1989;257(6):C1055–61.
47. Hotchkiss RS, Song S-K, Neil JJ, Chen RD, Manchester JK, Karl IE, et al. Sepsis does not impair tricarboxylic acid cycle in the heart. Am J Physiol Cell Physiol. 1991;260(1):C50–7.
48. +ATPase activity and raised lactate concentrations in septic shock: a prospective study. The Lancet. 2005;365(9462):871–5.
49. James JH, Luchette FA, McCarter FD, Fischer JE. Lactate is an unreliable indicator of tissue hypoxia in injury or sepsis. The Lancet. 1999;354(9177):505–8.
50. Langenberg C, Bellomo R, May C, Wan L, Egi M, Morgera S. Renal blood flow in sepsis. Crit Care. 2005;9(4):R363.
51. Langenberg C, Wan L, Egi M, May C, Bellomo R. Renal blood flow in experimental septic acute renal failure. Kidney Int. 2006;69(11):1996–2002.
52. Bihari S, Prakash S, Bersten AD. Post resusicitation fluid boluses in severe sepsis or septic shock: prevalence and efficacy (price study). Shock. 2013;40(1):28–34.
53. Lammi MR, Aiello B, Burg GT, Rehman T, Douglas IS, Wheeler AP, et al. Response to fluid boluses in the fluid and catheter treatment trial. Chest. 2015;148(4):919–26.
54. Dries DJ, Waxman K. Adequate resuscitation of burn patients may not be measured by urine output and vital signs. Crit Care Med. 1991;19(3):327–9.
55. Pruitt BA Jr. Protection from excessive resuscitation: “pushing the pendulum back”. J Trauma. 2000;49(3):567–8.
56. Egal M, Erler NS, de Geus HR, van Bommel J, Groeneveld AB. Targeting oliguria reversal in goal-directed hemodynamic management does not reduce renal dysfunction in perioperative and critically ill patients: a systematic review and meta-analysis. Anesth Analg. 2016;122(1):173–85.
57. Mohsenifar Z, Jasper A, Koerner S. Relationship between oxygen uptake and oxygen delivery in patients with pulmonary hypertension. Am Rev Respir Dis. 1988;138(1):69–73.
58. Dantzker DR, Foresman B, Gutierrez G. Oxygen supply and utilization relationships: a reevaluation. Am Rev Respir Dis. 1991;143(3):675–9.
59. Marik P, Bellomo R. A rational approach to fluid therapy in sepsis. Br J Anaesth. 2016;116(3): 339–49.
60. ® 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers. Ann Surg. 2012;256(1):18–24.
61. Bark BP, Öberg CM, Grände P-O. Plasma volume expansion by 0.9% NaCl during sepsis/systemic inflammatory response syndrome, after hemorrhage, and during a normal state. Shock. 2013;40(1):59–64.
62. Sánchez M, Jiménez-Lendínez M, Cidoncha M, Asensio M, Herrero E, Collado A, et al. Comparison of fluid compartments and fluid responsiveness in septic and non-septic patients. Anaesth Intensive Care. 2011;39(6):1022.
63. Nunes TSO, Ladeira RT, Bafi AT, de Azevedo LCP, Machado FR, Freitas FGR. Duration of hemodynamic effects of crystalloids in patients with circulatory shock after initial resuscitation. Ann Intensive Care. 2014;4(1):1.
64. Marx G, Vangerow B, Burczyk C, Gratz K, Maassen N, Meyer MC, et al. Evaluation of noninvasive determinants for capillary leakage syndrome in septic shock patients. Intensive Care Med. 2000;26(9):1252–8.
65. Glassford NJ, Eastwood GM, Bellomo R. Physiological changes after fluid bolus therapy in sepsis: a systematic review of contemporary data. Crit Care. 2014;18(6):1.
66. Woodcock TE, Woodcock TM. Revised Starling equation and the glycocalyx model of transvascular fluid exchange: an improved paradigm for prescribing intravenous fluid therapy. Br J Anaesth. 2012;108(3):384–94.
67. Persichini R, Silva S, Teboul J-L, Jozwiak M, Chemla D, Richard C, et al. Effects of norepinephrine on mean systemic pressure and venous return in human septic shock. Crit Care Med. 2012;40(12):3146–53.
68. Hamzaoui O, Georger J-F, Monnet X, Ksouri H, Maizel J, Richard C, et al. Early administration of norepinephrine increases cardiac preload and cardiac output in septic patients with life-threatening hypotension. Crit Care. 2010;14(4):1.
69. Monnet X, Jabot J, Maizel J, Richard C, Teboul J-L. Norepinephrine increases cardiac preload and reduces preload dependency assessed by passive leg raising in septic shock patients. Crit Care Med. 2011;39(4):689–94.
70. Gordon AC, Perkins GD, Singer M, McAuley DF, Orme RM, Santhakumaran S, et al. Levosimendan for the prevention of acute organ dysfunction in sepsis. N Engl J Med. 2016;375(17):1638–48.
71. Gordon AC, Mason AJ, Thirunavukkarasu N, Perkins GD, Cecconi M, Cepkova M, et al. Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. JAMA. 2016;316(5):509–18.
72. Rahal L, Garrido AG, Cruz RJ Jr, Silva E, Poli-de-Figueiredo LF. Fluid replacement with hypertonic or isotonic solutions guided by mixed venous oxygen saturation in experimental hypodynamic sepsis. J Trauma Acute Care Surg. 2009;67(6):1205–12.
73. Garrido A, Poli de Figueiredo L, Cruz RJ Jr, Silva E. Rocha e Silva M. Short-lasting systemic and regional benefits of early crystalloid infusion after intravenous inoculation of dogs with live Escherichia coli. Braz J Med Biol Res. 2005;38(6):873–84.
74. Lagoa CE, de Figueiredo LF, Cruz RJ, Silva E, Silva MR. Effects of volume resuscitation on splanchnic perfusion in canine model of severe sepsis induced by live Escherichia coli infusion. Crit Care. 2004;8(4):R221.
75. van Haren FM, Sleigh JW, Pickkers P, Van der Hoeven JG. Gastrointestinal perfusion in septic shock. Anaesth Intensive Care. 2007;35(5):679–94.
76. Ottosson J, Dawidson I, Brandberg A, Idvall J, Sandor Z. Cardiac output and organ blood flow in experimental septic shock: effect of treatment with antibiotics, corticosteroids, and fluid infusion. Circ Shock. 1991;35(1):14–24.
77. Ottosson J, Persson T, Dawidson I. Oxygen consumption and central hemodynamics in septic shock treated with antibiotics, fluid infusions, and corticosteroids. Crit Care Med. 1989;17(8):772–9.
78. Smith E III, Slivjak M, Egan J, Gagnon R, Arleth A, Esser K. Fluid resuscitation improves survival of endotoxemic or septicemic rats: possible contribution of tumor necrosis factor. Pharmacology. 1993;46(5):254–67.
79. Wilson MA, Chou MC, Spain DA, Downard PJ, Qian Q, Cheadle WG, et al. Fluid resuscitation attenuates early cytokine mRNA expression after peritonitis. J Trauma. 1996;41(4):622–7.
80. Natanson C, Danner RL, Reilly JM, Doerfler ML, Hoffman WD, Akin GL, et al. Antibiotics versus cardiovascular support in a canine model of human septic shock. Am J Physiol Heart Circ Physiol. 1990;259(5):H1440–7.
81. Oi Y, Åneman A, Svensson M, Ewert S, Dahlqvist M, Haljamäe H. Hypertonic saline-dextran improves intestinal perfusion and survival in porcine endotoxin shock. Crit Care Med. 2000;28(8):2843–50.
82. Schmidhammer R, Wassermann E, Germann P, Redl H, Ullrich R. Infusion of increasing doses of endotoxin induces progressive acute lung injury but prevents early pulmonary hypertension in pigs. Shock. 2006;25(4):389–94.
83. Bressack MA, Morton N, Hortop J. Group B streptococcal sepsis in the piglet: effects of fluid therapy on venous return, organ edema, and organ blood flow. Circ Res. 1987;61(5):659–69.
84. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345(19):1368–77.
85. Early Goal-Directed Therapy Collaborative Group of Zhejiang Province. The effect of early goal-directed therapy on treatment of critical patients with severe sepsis/septic shock: a multi-center, prospective, randomized, controlled study. Chin Crit Care Med. 2010;22(6):331.
86. Lin S-M, Huang C-D, Lin H-C, Liu C-Y, Wang C-H, Kuo H-P. A modified goal-directed protocol improves clinical outcomes in intensive care unit patients with septic shock: a randomized controlled trial. Shock. 2006;26(6):551–7.
87. Mouncey PR, Osborn TM, Power GS, Harrison DA, Sadique MZ, Grieve RD, et al. Trial of early, goal-directed resuscitation for septic shock. N Engl J Med. 2015;372(14):1301–11.
88. Yealy DM, Kellum JA, Huang DT, Barnato AE, Weissfeld LA, Pike F, et al. A randomized trial of protocol-based care for early septic shock. New Engl J Med. 2014;370(18):1683–93.
89. Peake SL, Delaney A, Bailey M, Bellomo R, Cameron PA, Cooper DJ, et al. Goal-directed resuscitation for patients with early septic shock. New Engl J Med. 2014;371(16):1496–506.
90. Angus DC, Barnato AE, Bell D, Bellomo R, Chong CR, Coats TJ, et al. A systematic review and meta-analysis of early goal-directed therapy for septic shock: the ARISE, ProCESS and ProMISe Investigators. Intensive Care Med. 2015;41(9):1549–60.
91. Ferrer R, Artigas A, Suarez D, Palencia E, Levy MM, Arenzana A, et al. Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study. Am J Respir Crit Care Med. 2009;180(9):861–6.
92. Lee SJ, Ramar K, Park JG, Gajic O, Li G, Kashyap R. Increased fluid administration in the first three hours of sepsis resuscitation is associated with reduced mortality: a retrospective cohort study. CHEST J. 2014;146(4):908–15.
93. Garland A, Kumar A, Waechter J. Early administration of crystalloid fluids reduces mortality in septic shock. Am J Respir Crit Care Med. 2010;181:A4097.
94. Murphy CV, Schramm GE, Doherty JA, Reichley RM, Gajic O, Afessa B, et al. The importance of fluid management in acute lung injury secondary to septic shock. CHEST J. 2009;136(1):102–9.
95. Carcillo JA, Davis AL, Zaritsky A. Role of early fluid resuscitation in pediatric septic shock. JAMA. 1991;266(9):1242–5.
96. Sadaka F, Juarez M, Naydenov S, O’Brien J. Fluid resuscitation in septic shock: the effect of increasing fluid balance on mortality. J Intensive Care Med. 2014;29(4):213–7.
97. Smith SH, Perner A. Higher vs. lower fluid volume for septic shock: clinical characteristics and outcome in unselected patients in a prospective, multicenter cohort. Crit Care. 2012;16(3):R76.
98. Boyd JH, Forbes J, Nakada TA, Walley KR, Russell JA. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med. 2011;39(2):259–65.
99. Samoni S, Vigo V, Resendiz LI, Villa G, De Rosa S, Nalesso F, et al. Impact of hyperhydration on the mortality risk in critically ill patients admitted in intensive care units: comparison between bioelectrical impedance vector analysis and cumulative fluid balance recording. Crit Care. 2016;20:95.
100. Sadaka F, Juarez M, Naydenov S, O’Brien J. Fluid resuscitation in septic shock the effect of increasing fluid balance on mortality. J Intensive Care Med. 2013:0885066613478899.
101. Cecconi M, Hofer C, Teboul JL, Pettila V, Wilkman E, Molnar Z, et al. Fluid challenges in intensive care: the FENICE study—a global inception cohort study. Intensive Care Med. 2015;41(9):1529–37.
102. Vandervelden S, Malbrain ML. Initial resuscitation from severe sepsis: one size does not fit all. Anaesthesiol Intensive Ther. 2015;47:s44–55.
103. Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006;354(24):2564–75.
104. Hoste EA, Maitland K, Brudney CS, Mehta R, Vincent JL, Yates D, et al. Four phases of intravenous fluid therapy: a conceptual model. Br J Anaesth. 2014;113(5):740–7.
105. Malbrain ML, Van Regenmortel N, Owczuk R. It is time to consider the four D’s of fluid management. Anaesthesiol Intensive Ther. 2015;47:s1–5.
106. Chen C, Kollef MH. Targeted fluid minimization following initial resuscitation in septic shock: a pilot study. Chest. 2015;148(6):1462–9.
107. Malbrain ML, Marik PE, Witters I, Cordemans C, Kirkpatrick AW, Roberts DJ, et al. Fluid overload, de-resuscitation, and outcomes in critically ill or injured patients: a systematic review with suggestions for clinical practice. Anaesthesiol Intensive Ther. 2014;46(5):361–80.
108. Hjortrup PB, Haase N, Bundgaard H, Thomsen SL, Winding R, Pettila V, et al. Restricting volumes of resuscitation fluid in adults with septic shock after initial management: the CLASSIC randomised, parallel-group, multicentre feasibility trial. Intensive Care Med. 2016;42(11):1695–705.
109. Investigators RRTS, Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, et al. An observational study fluid balance and patient outcomes in the Randomized Evaluation of Normal vs. Augmented Level of Replacement Therapy trial. Crit Care Med. 2012;40(6):1753–60.
110. Maitland K, Kiguli S, Opoka RO, Engoru C, Olupot-Olupot P, Akech SO, et al. Mortality after fluid bolus in African children with severe infection. N Engl J Med. 2011;364(26):2483–95.
111. Southall D, Samuels M. Treating the wrong children with fluids will cause harm: response to ‘mortality after fluid bolus in African children with severe infection’. Arch Dis Child. 2011;96(10):905–6.
112. Ford S, Visram A. Mortality after fluid bolus in African children with sepsis. N Engl J Med. 2011;365(14):1348.
113. Myburgh J, Finfer S. Causes of death after fluid bolus resuscitation: new insights from FEAST. BMC Med. 2013;11(1):1.
114. Maitland K, George EC, Evans JA, Kiguli S, Olupot-Olupot P, Akech SO, et al. Exploring mechanisms of excess mortality with early fluid resuscitation: insights from the FEAST trial. BMC Med. 2013;11(1):1.